3 free views remaining today

Noonan syndrome 3

ICD-10 Codes

Related ICD-10:

Description

Noonan Syndrome: A Rare Genetic Disorder

Noonan syndrome is a rare genetic disorder that affects various parts of the body, including the face, heart, and skeletal system. The condition is characterized by:

  • Mildly unusual facial features: People with Noonan syndrome may have distinctive facial characteristics, such as a webbed neck or low-set ears [3].
  • Short stature: Individuals with Noonan syndrome often experience short stature, which can range from mild to severe [3].
  • Heart defects: Heart problems are common in people with Noonan syndrome, including issues with the heart's structure and function [3].
  • Bleeding problems: Some individuals with Noonan syndrome may experience bleeding difficulties due to platelet abnormalities [3].
  • Skeletal malformations: The condition can also affect the skeletal system, leading to various malformations, such as short fingers or toes [3].

Overall, Noonan syndrome is a complex and highly variable genetic disorder that affects multiple systems in the body.

Additional Characteristics

  • Short stature
  • Heart defects
  • Skeletal malformations
  • Bleeding problems
  • Mildly unusual facial features

Signs and Symptoms

Noonan Syndrome Signs and Symptoms

Noonan syndrome is characterized by a range of physical and developmental features, which can vary in severity from person to person. Some common signs and symptoms of the condition include:

  • Unusual facial features: A tall forehead, wide-set eyes, lower-set ears, and a shorter neck are often present.
  • Short stature: Many individuals with Noonan syndrome experience restricted growth, resulting in short stature.
  • Heart problems: Congenital heart disease is a common feature of the condition, which can lead to various complications if left untreated.

These symptoms are typically present at birth or become apparent during early childhood. The severity and range of symptoms can vary significantly among affected individuals, making it essential for accurate diagnosis and management by medical professionals.

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Noonan Syndrome

Noonan syndrome can be diagnosed through various tests, which may aid in identifying the condition and its related disorders. Some of these diagnostic tests include:

  • Genomic DNA (gDNA) testing: This test analyzes the genetic material to identify any mutations associated with Noonan syndrome.
  • Next-generation sequencing (NGS): This is a type of genetic testing that can be used to confirm the diagnosis of Noonan syndrome by analyzing the genes associated with the condition.
  • Blood or cheek swab test: A simple blood or cheek swab test can be performed to diagnose Noonan syndrome through genetic testing.

These tests may also aid in diagnosing related disorders, such as:

  • Noonan syndrome with multiple lentigines
  • Cardiofaciocutaneous syndrome
  • Costello syndrome

It's essential to consult a healthcare provider for proper evaluation and diagnosis. They will perform a detailed family history, medical history, and physical examination to make an accurate diagnosis.

References: [3] This test may aid in the diagnosis of Noonan syndrome, Noonan syndrome with multiple lentigines, cardiofaciocutaneous syndrome, Costello syndrome, or a related disorder. [8] How is Noonan syndrome diagnosed? · Complete blood count (CBC). · Chest X-ray. · CT scan. · Echocardiogram. · Electrocardiogram (EKG). · Genetic tests. · Ultrasound.

Additional Diagnostic Tests

  • Next-generation sequencing (NGS)
  • Genomic DNA (gDNA) testing
  • Blood or cheek swab test

Treatment

Treatment Options for Noonan Syndrome

Noonan syndrome is a genetic disorder that affects various aspects of an individual's health, including their heart, growth rate, and learning abilities. While there is no cure for the condition, several treatment options are available to manage its symptoms.

  • Cardiac Therapy: Individuals with Noonan syndrome often experience cardiac problems, such as heart defects or murmurs. Cardiac therapy can help alleviate these issues by addressing any underlying heart conditions.
  • Growth Hormone Therapy: Growth hormone therapy is a common treatment for individuals with Noonan syndrome who have growth hormone deficiency. This therapy involves administering synthetic human growth hormone to stimulate growth and development.

According to search result [5], the treatment of Noonan syndrome focuses on managing its symptoms, which may include cardiac therapy and growth hormone therapy. Additionally, meeting with a genetic counselor can help families understand their child's condition and develop a personalized care plan (search result [6]).

It is essential to note that while these treatments can improve the quality of life for individuals with Noonan syndrome, they do not cure the condition itself. A team of healthcare professionals, including doctors, nurses, therapists, and social workers, work together to provide comprehensive care for affected children (search result [6]).

References: * Search result [5]: Treatment of Noonan syndrome. * Search result [6]: Meeting with a genetic counselor can help families understand their child's condition and develop a personalized care plan.

Recommended Medications

  • Growth Hormone Therapy
  • Cardiac Therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Noonan Syndrome: A Complex Genetic Disorder

Noonan syndrome (NS) is a rare genetic disorder that affects approximately 1 in 1000 to 1 in 2500 live births [4]. It is characterized by short stature, typical facial dysmorphology, and congenital heart defects [4]. The main facial features of NS include hypertelorism with down-slanting palpebral fissures, ptosis, and low-set posteriorly rotated ears with a thickened helix [4].

Differential Diagnosis

The differential diagnosis for Noonan syndrome includes Williams syndrome, intrauterine exposure to primidone, fetal alcohol syndrome, and Aarskog syndrome [6]. Other conditions that may be considered in the differential diagnosis include Turner syndrome, which is typically seen in females and is differentiated from NS by demonstration of a sex chromosome abnormality on cytogenetic studies [1].

Cardiovascular Defects

The cardiovascular defects most commonly associated with Noonan syndrome are atrial septal defect, pulmonary stenosis, and hypertrophic cardiomyopathy [8]. Approximately two-thirds of patients exhibit cardiac symptoms [8].

Developmental Delay

Short stature and global developmental delay or intellectual disabilities are more common in patients with NS-related disorders than in patients with NS alone [7]. Developmental delay of variable degree is also a characteristic feature of Noonan syndrome [5].

Diagnostic Criteria

Diagnostic criteria have been developed to aid in the diagnosis of Noonan syndrome. These criteria include clinical and genetic features, such as short stature, typical facial dysmorphology, congenital heart defects, and developmental delay [9]. A team-based interprofessional care approach is recommended for affected patients.

In conclusion, Noonan syndrome is a complex genetic disorder that requires careful consideration of differential diagnoses and diagnostic criteria. The cardiovascular defects associated with NS are significant, and developmental delay is a common feature of the condition.

References:

[1] Turner syndrome, typically seen in females, is differentiated from Noonan syndrome by demonstration of a sex chromosome abnormality on cytogenetic studies. [4] The main facial features of NS include hypertelorism with down-slanting palpebral fissures, ptosis, and low-set posteriorly rotated ears with a thickened helix. [5] Developmental delay of variable degree is also a characteristic feature of Noonan syndrome. [6] The differential diagnosis for Noonan syndrome includes Williams syndrome, intrauterine exposure to primidone, fetal alcohol syndrome, and Aarskog syndrome. [7] Short stature and global developmental delay or intellectual disabilities are more common in patients with NS-related disorders than in patients with NS alone. [8] Approximately two-thirds of patients exhibit cardiac symptoms. [9] Diagnostic criteria have been developed to aid in the diagnosis of Noonan syndrome.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1595
owl#annotatedSource
t341182
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
MIM:609942
oboInOwl#id
DOID:0060581
core#notation
DOID:0060581
oboInOwl#hasAlternativeId
DOID:0070103
IAO_0000115
A Noonan syndrome that has_material_basis_in heterozygous mutation in the KRAS gene.
rdf-schema#label
Noonan syndrome 3
oboInOwl#hasExactSynonym
NS3
rdf-schema#subClassOf
t340970
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/Q87.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.